Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 453

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Open access
van Bon, Lenny, Affandi, Alsya J., Broen, Jasper, Christmann, Romy B., Marijnissen, Renoud J., Stawski, Lukasz, Farina, Giuseppina A., Stifano, Giuseppina, Mathes, Allison L., Cossu, Marta, York, Michael, Collins, Cindy, Wenink, Mark, Huijbens, Richard, Hesselstrand, Roger, Saxne, Tore, DiMarzio, Mike, Wuttge, Dirk, Agarwal, Sandeep K., Reveille, John D., Assassi, Shervin, Mayes, Maureen, Deng, Yanhui, Drenth, Joost P.H., de Graaf, Jacqueline, den Heijer, Martin, Kallenberg, Cees G.M., Bijl, Marc, Loof, Arnoud, van den Berg, Wim B., Joosten, Leo A.B., Smith, Vanessa, de Keyser, Filip, Scorza, Rafaella, Lunardi, Claudio, van Riel, Piet L.C.M., Vonk, Madelon, van Heerde, Waander, Meller, Stephan, Homey, Bernhard, Beretta, Lorenzo, Roest, Mark, Trojanowska, Maria, Lafyatis, Robert, Radstake, Timothy R.D.J.·2014·New England Journal of Medicine

Abstract

BACKGROUND: Plasmacytoid dendritic cells have been implicated in the pathogenesis of systemic sclerosis through mechanisms beyond the previously suggested production of type I interferon. METHODS: We isolated plasmacytoid dendritic cells from healthy persons and from patients with systemic sclerosis who had distinct clinical phenotypes. We then performed proteome-wide analysis and validated these observations in five large cohorts of patients with systemic sclerosis. Next, we compared the results with those in patients with systemic lupus erythematosus, ankylosing spondylitis, and hepatic fibrosis. We correlated plasma levels of CXCL4 protein with features of systemic sclerosis and studied the direct effects of CXCL4 in vitro and in vivo. RESULTS: Proteome-wide analysis and validation showed that CXCL4 is the predominant protein secreted by plasmacytoid dendritic cells in systemic sclerosis, both in circulation and in skin. The mean (±SD) level of CXCL4 in patients with systemic sclerosis was 25,624±2652 pg per milliliter, which was significantly higher than the level in controls (92.5±77.9 pg per milliliter) and than the level in patients with systemic lupus erythematosus (1346±1011 pg per milliliter), ankylosing spondylitis (1368±1162 pg per milliliter), or liver fibrosis (1668±1263 pg per milliliter). CXCL4 levels correlated with skin and lung fibrosis and with pulmonary arterial hypertension. Among chemokines, only CXCL4 predicted the risk and progression of systemic sclerosis. In vitro, CXCL4 down-regulated expression of transcription factor FLI1, induced markers of endothelial-cell activation, and potentiated responses of toll-like receptors. In vivo, CXCL4 induced the influx of inflammatory cells and skin transcriptome changes, as in systemic sclerosis. CONCLUSIONS: Levels of CXCL4 were elevated in patients with systemic sclerosis and correlated with the presence and progression of complications, such as lung fibrosis and pulmonary arterial hypertension. (Funded by the Dutch Arthritis Association and others.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1114576

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 453

Metadata

Authors
van Bon, L., Affandi, A. J., Broen, J., Christmann, R. B., Marijnissen, R. J., Stawski, L., Farina, G. A., Stifano, G., Mathes, A. L., Cossu, M., York, M., Collins, C., Wenink, M., Huijbens, R., Hesselstrand, R., Saxne, T., DiMarzio, M., Wuttge, D., Agarwal, S. K., Reveille, J. D., Assassi, S., Mayes, M., Deng, Y., Drenth, J. P. H., de Graaf, J., den Heijer, M., Kallenberg, C. G. M., Bijl, M., Loof, A., van den Berg, W. B., Joosten, L. A. B., Smith, V., de Keyser, F., Scorza, R., Lunardi, C., van Riel, P. L. C. M., Vonk, M., van Heerde, W., Meller, S., Homey, B., Beretta, L., Roest, M., Trojanowska, M., Lafyatis, R., & Radstake, T. R. D. J.
Venue
New England Journal of Medicine
Published
2014-01-30
Volume
370
Issue
5
Pages
433-443
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2154576801
Cited by
453
References
36
FWCI
21.57
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis. https://app.cochat.ai/papers/10.1056/nejmoa1114576
The paper
van Bon, L., Affandi, A. J., Broen, J., Christmann, R. B., Marijnissen, R. J., Stawski, L., Farina, G. A., Stifano, G., Mathes, A. L., Cossu, M., York, M., Collins, C., Wenink, M., Huijbens, R., Hesselstrand, R., Saxne, T., DiMarzio, M., Wuttge, D., Agarwal, S. K., . . . Radstake, T. R. D. J. (2014). Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1114576

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.